Proud contributor to public health
Navamedic is a nordic pharma company and a reliable supplier of high-quality products.
-
Employees
45
-
Revenue 2023 (MNOK)
512
-
EBITDA 2023 (MNOK)
51.6
-
Number of products
84
-
Countries where products are sold
13
-
Established in
2002
Financial Results
Take part of up-to-date financial results in our quarterly webcasts and reports.
View results
New treatment for erectile dysfunction
Navamedic is now launching Eroxon® across pharmacies in Finland. Eroxon® will be the first clinically proven over-the-counter topical treatment for the treatment of erectile dysfunction in men in Finland.
Learn more